Navigation Links
AquaStar Holdings, Inc.'s Subsidiary Signs Multi-Million Dollar Venture Accelerator Agreement To Develop Portable Healthcare Diagnostic Technology
Date:4/12/2011

SANTA ANA, Calif., April 12, 2011 /PRNewswire/ -- AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company's wholly-owned subsidiary, SUTIMCo, has signed a Venture Acceleration Agreement with Capwave Sensor, Inc., valued at $2,790,000. Capwave is the maker of a revolutionary portable Enzyme-Linked ImmunoSorbent Assay (ELISA) test platform. According to the terms of the Agreement, SUTIMCo will assist Capwave with development and commercialization of its technology for a period of three years at $77,500 per month.

Developed at the State University of New York Binghamton by Professor Omowunmi Sadik, Capwave is a rapid, sensitive, and portable Enzyme-Linked ImmunoSorbent Assay (ELISA) platform for use anywhere antibody based testing can be done and is capable of detecting Bioweapons (anthrax, bacillus globigii), Biomarkers (cancer, stem cells), Toxins (E. coli and salmonella in foodborne illness), Contaminants and Diseases (both viral and bacterial). According to the Centers for Disease Control and Prevention (CDC), about 48 million people (1 in 6 Americans) get sick, 128,000 are hospitalized, and 3,000 die each year from foodborne diseases. The ability to detect the foodborne pathogens responsible for these illnesses in a timely fashion has the potential to offer faster treatment, reduce hospital stays and prevent deaths.

SUTIMCo operates as a Venture Accelerator, offering development services to start-up companies for up to three years.  The company launches and manages businesses in health & wellness, energy/environmental, advanced materials, sensors and electronic technology ventures to build upon the research of a host of prestigious Universities across the United States. SUTIMCo's business model and methodologies help create high growth companies taking innovation from laboratory to marketplace.

"We are excited to have the opportunity to collaborate with Capwave," stated Malcolm Lennie, President of AquaStar Holdings, Inc. "It is SUTIMCo's ultimate desire to help drive transformative research that can change the world."

In further news, AquaStar recently announced that SUTIMCo is participating in the evaluation of technology-based projects from six other major American Universities including UC San Diego, Arizona State University and Penn State University for their viability to commercialize the technology and take it to market faster.

For more information on SUTIMCo, its portfolio companies, and University partners, please visit; http://www.suti.com

About AquaStar Holdings, Inc.:

AquaStar Holdings, Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. AquaStar Holdings, through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, AquaStar Holdings can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.


'/>"/>
SOURCE AquaStar Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VHGI Holdings, Inc. Announces Expansion of Sun Gold Project
2. Innophos Holdings, Inc. Declares Dividend of $0.25 Per Share; Increases Rate By 47%
3. Bacterin International Holdings, Inc. Schedules Conference Call to Present Fourth Quarter and Full Year 2010 Financial Results
4. Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex
5. China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
6. Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
7. Radiation Therapy Services Holdings, Inc. Acquires Medical Developers, LLC
8. China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011
9. Innophos Holdings, Inc. Announces Annual Meeting
10. Technest Holdings, Inc. to Acquire AccelPath, LLC; Issue Contingent Value Rights to Common Stockholders; and Issue Shares of Its Series E 5% Convertible Preferred Stock
11. Hill-Rom Holdings, Inc. Hosts Fiscal 2011 First Quarter Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):